Thrombotic microangiopathies in critically ill children: The MATUCIP registry in Spain
- PMID: 36842880
- DOI: 10.1016/j.anpede.2023.02.006
Thrombotic microangiopathies in critically ill children: The MATUCIP registry in Spain
Abstract
Introduction: Thrombotic microangiopathies (TMA) are rare diseases usually presenting with renal, haematological, neurologic and cardiovascular involvement and nonspecific but severe symptoms. A registry of TMA cases managed in Spanish paediatric intensive care units (the MATUCIP Registry) was established with the aim of gaining knowledge on their clinical characteristics, diagnosis and acute-phase treatment.
Methods: We conducted a prospective multicentre observational study in 20 paediatric intensive care units (PICUs) in Spain from January 2017 to December 2021 in children aged more than 1 month with TMAs, who were followed up through the discharge from the PICU.
Results: The sample included 97 patients (51.5% female) with a median age of 2.6 years (interquartile range [IQR], 1.6-5.7). The initial manifestations were gastrointestinal (74.2%), respiratory (14.4%), fever (5.2%), neurologic (3.1%) and other (3.1%). At admission, 75.3% of patients had microangiopathic haemolytic anaemia, 95.9% thrombocytopenia and 94.8% acute kidney injury. Of the total sample, 57.7% of patients received a diagnosis of Shiga toxin-associated haemolytic uraemic syndrome (HUS), 14.4% of Streptococcus pneumoniae-associated HUS, 15.6% of atypical HUS, 10.3% of secondary TMA and 2.1% of thrombotic thrombocytopenic purpura. Eighty-seven patients (89.7%) developed arterial hypertension, and 49.5% gastrointestinal, 22.7% respiratory, 25.8% neurologic and 12.4% cardiac manifestations. Also, 60.8% required renal replacement therapy and 2.1% plasma exchange. Twenty patients received eculizumab. The median PICU stay was 8.5 days (IQR, 5-16.5). Two children died.
Conclusions: The MATUCIP registry demonstrates the clinical variability of TMA cases requiring admission to the PICU. Knowledge of the presentation and outcomes of TMAs can facilitate early aetiological diagnosis. This registry can help improve our understanding of the clinical spectrum of these diseases, for which there is a dearth of published data.
Keywords: Acute kidney injury; Anemia hemolítica microangiopática; Cuidados intensivos pediátricos; Haemolytic uraemic syndrome; Insuficiencia renal aguda; Microangiopathic haemolytic anaemia; Microangiopatía trombótica; Paediatricintensive care; Síndrome hemolítico urémico; Thrombocytopenia; Thrombotic microangiopathy; Trombocitopenia.
Copyright © 2022 Asociación Española de Pediatría. Published by Elsevier España, S.L.U. All rights reserved.
Similar articles
-
Diagnostic-therapeutic algorithm for thrombotic microangiopathy. A report of two cases.Rev Esp Anestesiol Reanim (Engl Ed). 2022 Mar;69(3):179-182. doi: 10.1016/j.redare.2020.11.015. Epub 2022 Mar 10. Rev Esp Anestesiol Reanim (Engl Ed). 2022. PMID: 35283062
-
Where are we with haemolytic uremic syndrome?Med Clin (Barc). 2018 Oct 23;151(8):329-335. doi: 10.1016/j.medcli.2018.02.016. Epub 2018 Apr 24. Med Clin (Barc). 2018. PMID: 29699703 Review. English, Spanish.
-
An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document.Nefrologia. 2015;35(5):421-47. doi: 10.1016/j.nefro.2015.07.005. Epub 2015 Oct 9. Nefrologia. 2015. PMID: 26456110 English, Spanish.
-
Early Differentiation of Shiga Toxin-Associated Hemolytic Uremic Syndrome in Critically Ill Adults With Thrombotic Microangiopathy Syndromes.Crit Care Med. 2018 Sep;46(9):e904-e911. doi: 10.1097/CCM.0000000000003292. Crit Care Med. 2018. PMID: 29979220
-
[Thrombotic microangiopathy/haemolytic uraemic syndrome. Histopathology update].Rev Esp Patol. 2018 Jul-Sep;51(3):170-177. doi: 10.1016/j.patol.2017.10.007. Epub 2017 Dec 16. Rev Esp Patol. 2018. PMID: 30012310 Review. Spanish.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources